Since its beginnings, the United States Pharmacopeial Convention (USP) has been concerned with setting quality standards for botanicals and minerals. On the eve of the 20th anniversary of the Dietary Supplement Health and Education Act (DSHEA), Dr. Srini Srinivasan, Executive Vice President, Special Assignments and Chief Science Officer at USP, reflects on the dramatic growth of the dietary supplement industry, USP’s changing role as a standards setting body and the impact of DSHEA.
Today, peptides represent one of the fastest growing segments in the pharmaceutical market. Hence, being able to manufacture peptides that are consistent in makeup and quality is an important priority for manufacturers of this drug class. This article discusses how the global pharmaceutical landscape continues to transform and how quality standards will play a growing role in the manufacture of these drugs.